This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Jiangsu Vcare Pharma Tech Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Daan Qin: Innovator in Janus Kinase Inhibitors
Introduction
Daan Qin is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Janus kinase (JAK) family inhibitors. His work focuses on innovative solutions for treating inflammatory diseases.
Latest Patents
Daan Qin holds a patent for a Janus kinase (JAK) family inhibitor, which includes a 7-azaindole derivative. This compound is designed for use in pharmaceutical compositions aimed at preventing or treating diseases related to the JAK family. Specifically, his invention addresses inflammatory diseases associated with protein tyrosine kinase.
Career Highlights
Daan Qin is affiliated with Jiangsu Vcare Pharma Tech Co., Ltd., where he continues to advance his research and development efforts. His expertise in medicinal chemistry and pharmacology has positioned him as a key player in the pharmaceutical industry.
Collaborations
Daan has collaborated with notable colleagues, including Yong Wu and Yanchun Gong, to further enhance the impact of his research. Their combined efforts contribute to the innovative environment at Jiangsu Vcare Pharma Tech Co., Ltd.
Conclusion
Daan Qin's work in developing Janus kinase inhibitors represents a significant advancement in the treatment of inflammatory diseases. His contributions to the pharmaceutical field are noteworthy and continue to influence future research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile